US puts J&J in charge of plant that botched Covid vaccine, removes AstraZeneca

US puts J&J in charge of plant that botched Covid vaccine, removes AstraZeneca
US puts J&J in charge of plant that botched Covid vaccine, removes AstraZeneca

Hello and welcome to the details of US puts J&J in charge of plant that botched Covid vaccine, removes AstraZeneca and now with the details

Nevin Al Sukari - Sana'a - A vial and syringe are seen in front of a displayed Johnson&Johnson; logo in this illustration taken January 11, 2021. — Reuters pic

Subscribe to our Telegram channel for the latest updates on news you need to know.


WASHINGTON, April 5 — The United States has put Johnson and Johnson in charge of a plant that ruined 15 million doses of its Covid-19 vaccine and has stopped British drugmaker AstraZeneca Plc from using the facility, a senior health official said on Saturday.

J&J said it was “assuming full responsibility” of the Emergent BioSolutions facility in Baltimore, reiterating that it will deliver 100 million doses to the government by the end of May.

In a separate statement late yesterday, Emergent said it expects to align with the US government and AstraZeneca to ramp down manufacturing for AstraZeneca’s Covid-19 vaccine at its Baltimore plant.

The Department of Health and Human Services has also increased Emergent’s order by US$23 million (RM95 million) for expansion of production specific to J&J’s vaccine doses, Emergent added.

“The US$23 million will be used for the purchase of biologics manufacturing equipment specific to Johnson & Johnson’s Covid-19 vaccine for the potential expansion of manufacturing of that bulk drug substance into a third suite of Emergent’s Baltimore Bayview facility,” the company said.

The Department of Health and Human Services facilitated the move, the health official said in an email, asking not to be named due to the sensitivity of the matter.

AstraZeneca, whose vaccine has not been approved in the United States, said it will work with President Joe Biden’s administration to find an alternative site to produce its vaccine.

White House officials did not immediately respond to a request for comment.

The development, first reported by the New York Times, further hampers AstraZeneca’s efforts in the United States. The government has criticised the drugmaker for using outdated data in the results of its vaccine trial. It later revised its study.

Workers at the Emergent BioSolutions plant several weeks ago conflated ingredients for the J&J and AstraZeneca vaccines, the Times said earlier in the week. J&J said at the time the ruined batch had not advanced to the fill-and-finish stage.

The government’s move to have the facility make only the J&J single-dose vaccine is meant to avoid future mix-ups, the Times said, citing two senior federal health officials.

The top US infectious disease doctor told Reuters on Thursday the country may not need AstraZeneca’s vaccine even if it wins approval.

The United States has loan deals to send Mexico and Canada roughly four million doses of the AstraZeneca vaccine, made at its US facility. — Reuters

These were the details of the news US puts J&J in charge of plant that botched Covid vaccine, removes AstraZeneca for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Myanmar teen describes junta's brutal treatment of detained women
NEXT India's lauds Gulf assistance in fighting COVID-19